Excessive pricing or 'price gouging' of essential hygiene and medical products during the current global pandemic could be prevented, claims a new paper from the University of Portsmouth.
Jul 16, 2020
0
0
US pharmaceutical giant Johnson and Johnson announced Monday an immediate cut in the price of its tuberculosis treatment course—a move NGOs have long been calling for.
Jul 6, 2020
0
4
If you plan to hit the road for the Fourth of July, there are some factors you may want to consider for traveling in the age of COVID-19.
Jul 1, 2020
0
1
Is the basic research that goes into the development of new drugs more efficiently conducted by public-sector scientists, pharmaceutical firms, or independent private laboratories? What role do each of these groups play in ...
Jun 29, 2020
0
2
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other ...
Jun 29, 2020
0
7
Nearly 9 in 10 U.S. adults are "very" (55%) or "somewhat" (33%) concerned that the pharmaceutical industry will leverage the COVID-19 pandemic to raise drug prices. Similarly, 84% are very or somewhat concerned that the general ...
Jun 18, 2020
0
1
Tobacco industry discounting is linked to higher cigarette consumption the following year, finds an analysis of the impact of pricing differentials in 23 European countries and published online in the journal Tobacco Control.
Jun 16, 2020
0
2
British pharmaceuticals group AstraZeneca has approached US rival Gilead Sciences over a possible record merger, Bloomberg reported, as the pair spearhead treatments for COVID-19.
Jun 8, 2020
0
1
University of Virginia researchers are pioneering the use of focused ultrasound to defy the brain's protective barrier so that doctors could, at last, deliver many treatments directly into the brain to battle neurological ...
May 6, 2020
0
359
After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual ...
May 1, 2020
0
4
